Amphion Innovations (AMP)


Latest News

Amphion update on Polarean Imaging

Amphion Innovations has issued an update regarding its partner company Polarean Imaging Limited, in which Amphion ...

Update on Polarean Imaging Limited

Miscellaneous medium priority announcements

DataTern case against MicroStrategy dismissed

Amphion Innovations said a case brought by its wholly-owned subsidiary DataTern against MicroStrategy Inc and certain...

Order Dismissing DataTern Case

Miscellaneous medium priority announcements

All News

10-11-17Amphion update on Polarean Imaging StockMarketWire
10-11-17Update on Polarean Imaging LimitedRNS
02-11-17DataTern case against MicroStrategy dismissed StockMarketWire
02-11-17Order Dismissing DataTern CaseRNS
11-10-17Related Party TransactionRNS
05-10-17Amphion partner releases positive clinical resultsStockMarketWire
05-10-17Partner Company releases positive clinical resultsRNS
29-09-17Amphion revenues rise StockMarketWire
29-09-17Half-year ReportRNS
25-09-17Holding(s) in CompanyRNS
25-09-17Sale of Partner Company SharesRNS
30-08-17Amphion reduces stake in Motif BioStockMarketWire
30-08-17Sale of partner company sharesRNS
30-08-17Holding(s) in CompanyRNS
01-08-17AGM StatementRNS
28-06-17FTSE falls on mixed bag led by utilities, oil majorsStockMarketWire
28-06-17Final ResultsRNS
31-05-17Amphion partner company agrees merger StockMarketWire
31-05-17Partner Company m2m Imaging merger updateRNS
23-05-17Amphion draws down additional $1.5mStockMarketWire
22-05-17Additional Draw Down on Loan FacilityRNS
07-02-17Amphion draws down additional $500,000StockMarketWire
07-02-17Additional Draw Down on Loan FacilityRNS
01-02-17Holding(s) in CompanyRNS
30-12-16Holding(s) in CompanyRNS
16-12-16Director/PDMR ShareholdingRNS
09-12-16Director/PDMR ShareholdingRNS
24-11-16Holding(s) in CompanyRNS
08-09-16Amphion re-negotiates terms of Motif CPNStockMarketWire
08-09-16Re-negotiated terms of Motif CPNRNS
07-09-16Amphion NAV up StockMarketWire
07-09-16Interim Results for the six months to 30 June 2016RNS
22-08-16Additional Draw Down on Loan FacilityRNS
03-08-16Holding(s) in CompanyRNS
29-07-16Results of AGM and Directorate ChangeRNS
18-07-16Transfer of SharesRNS
13-07-16Amphion partner Motif Bio to list on NASDAQStockMarketWire
13-07-16FTSE mixed ahead of May becoming PMStockMarketWire
13-07-16Notice of Intention to List on NASDAQ by Motif BioRNS
13-07-16Additional Draw Down on Loan FacilityRNS

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account